News Headlines Article

FDA approves $93K prostate cancer vaccine
USA Today

The Food and Drug Administration on Thursday approved the first vaccine to treat prostate cancer — or any cancer — the culmination of decades of research into harnessing the immune system to fight tumors. The $93,000 vaccine, Provenge, doesn’t prevent cancer, unlike the polio shot or recently approved vaccines that block infection with viruses that cause most cervical tumors. Provenge also doesn’t cure cancer.